09.23.19
A study published in the journal Physiology and Behavior has shown Lutemax 2020 from OmniActive Health Technologiescan positively affect cognitive performance.
The six-month randomized, double-blind, placebo-controlled study involved 59 young, healthy men and women subjects between 18-25 years old.
Supplementation with Lutemax 2020, which contains lutein and enhanced levels of zeaxanthin isomers, showed significant relationships between the changes in serum/retinal levels of lutein and zeaxanthin isomers, brain-derived neurotrophic factor (BDNF), and reduced inflammation, which led to improvements in cognitive performance.
"Compelling results such as these lend credence to the idea that macular carotenoids play a vital role in not only the eyes but also the brain by interrupting inflammatory pathways that can lead to a reduction in BDNF, which plays a role in learning and memory," said James Stringham, PhD, co-researcher and author of the publication.
An accumulating amount of science links oxidative and inflammatory stress with reductions in neurotrophic factors such as BDNF, stress resilience, and cognitive function. Given the established antioxidant and anti-inflammatory capacity of the macular carotenoids in the eye, and since the eyes are an extension of neural tissue, the authors examined how supplementation with Lutemax 2020 can impact BDNF and cognitive performance.
"This new publication on Lutemax 2020 strengthens the notion that the eyes and brain are connected, and supplementing with a combination of lutein, RS-zeaxanthin and RR (meso)-zeaxanthin can positively influence outcomes associated with vision, cognition and stress," said Arun Balakrishnan, chief strategy officer, OmniActive. "As consumer demand for natural solutions to support cognitive function and performance continues to grow, our science shows that Lutemax 2020 can fill this need in the market."
The six-month randomized, double-blind, placebo-controlled study involved 59 young, healthy men and women subjects between 18-25 years old.
Supplementation with Lutemax 2020, which contains lutein and enhanced levels of zeaxanthin isomers, showed significant relationships between the changes in serum/retinal levels of lutein and zeaxanthin isomers, brain-derived neurotrophic factor (BDNF), and reduced inflammation, which led to improvements in cognitive performance.
"Compelling results such as these lend credence to the idea that macular carotenoids play a vital role in not only the eyes but also the brain by interrupting inflammatory pathways that can lead to a reduction in BDNF, which plays a role in learning and memory," said James Stringham, PhD, co-researcher and author of the publication.
An accumulating amount of science links oxidative and inflammatory stress with reductions in neurotrophic factors such as BDNF, stress resilience, and cognitive function. Given the established antioxidant and anti-inflammatory capacity of the macular carotenoids in the eye, and since the eyes are an extension of neural tissue, the authors examined how supplementation with Lutemax 2020 can impact BDNF and cognitive performance.
"This new publication on Lutemax 2020 strengthens the notion that the eyes and brain are connected, and supplementing with a combination of lutein, RS-zeaxanthin and RR (meso)-zeaxanthin can positively influence outcomes associated with vision, cognition and stress," said Arun Balakrishnan, chief strategy officer, OmniActive. "As consumer demand for natural solutions to support cognitive function and performance continues to grow, our science shows that Lutemax 2020 can fill this need in the market."
